Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, and in continuation to our earlier intimation letter dated 29th October, 2025 regarding DR Axion India Private Limited (\DR Axion\), a wholly owned subsidiary of the Company, setting up of the new plant/unit/factory in the Chennai Metropolitan Area, Tamil Nadu, we wish to inform you that DR Axion has on 19th December, 2025, entered into a Share Purchase Agreement (\SPA\) for the direct acquisition of 100% of the paid up equity shares of Suprash Developers Private Limited (\Suprash). DR Axion will also Indirectly acquire the Wholly owned subsidiary of Suprash i.e Srikara Technologies Private Limited (\Srikara\).